| Literature DB >> 28951297 |
Devesh Tewari1, Seyed Fazel Nabavi2, Seyed Mohammad Nabavi3, Antoni Sureda4, Ammad Ahmad Farooqi5, Atanas G Atanasov6, Rosa Anna Vacca7, Gautam Sethi8, Anupam Bishayee9.
Abstract
Activator protein 1 (AP-1) is a key transcription factor in the control of several cellular processes responsible for cell survival proliferation and differentiation. Dysfunctional AP-1 expression and activity are involved in several severe diseases, especially inflammatory disorders and cancer. Therefore, targeting AP-1 has recently emerged as an attractive therapeutic strategy for cancer prevention and therapy. This review summarizes our current understanding of AP-1 biology and function as well as explores and discusses several natural bioactive compounds modulating AP-1-associated signaling pathways for cancer prevention and intervention. Current limitations, challenges, and future directions of research are also critically discussed.Entities:
Keywords: Activator protein 1; Apoptosis; Caffeic acid (PubChem CID: 689043); Cancer; Curcumin (PubChem CID: 969516); Inflammation; Isohamnetin (PubChem CID: 15817847); Kaempferide (PubChem CID: 5281666); Natural compounds; Quercetin (PubChem CID: 5280343); Resveratrol (PubChem CID: 445154); Viscolin (PubChem CID: 16079989)
Mesh:
Substances:
Year: 2017 PMID: 28951297 DOI: 10.1016/j.phrs.2017.09.014
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658